Cedars-Sinai Cancer

09/17/2026

Dr.Andrew Hung is corresponding author on a study published in npj Digital Medicine titled “End to End AI System for Surgical Gesture Sequence Recognition and Clinical Outcome Prediction. The paper describes Frame-to-Outcome (F2O), an AI-based system capable of analyzing videos from the nerve-sparing portion of robot-assisted prostate cancer surgery.

F2O could analyze surgeons’ techniques and it was able to match expert human reviewers in predicting patient outcomes. This innovative system can greatly reduce the time spent analyzing surgical performance and potentially provide objective feedback on techniques associated with successful patient recovery.

Read the Cedars-Sinai Newsroom article for more details: https://www.cedars-sinai.org/newsroom/ai-analyzes-surgical-technique-to-improve-prostate-cancer-care/

Click to read the paper: https://www.nature.com/articles/s41746-026-02927-5

09/17/2026

The ASPIRE Asian American Cohort Study is the first nationwide study representing all Asian ethnic groups. By joining, you'll help us better understand the causes of cancer in diverse Asian American communities. aspirecohort.ucsf.edu

Be part a historic nationwide effort to prevent cancer in Asian American communities!

Enroll now!*
https://aspireparticipant.ucsf.edu/enroll/aspire?site=cedars-sinai

*Please indicate how you heard about this study on the registration form (e.g., Cedars-Sinai Cancer Facebook)

09/17/2026

If you are interested in advancing medical research and improving patient lives, there is a position for you at Cedars-Sinai Cancer!

We are seeking a Clinical Research Coordinator III who will work independently providing study coordination and ensure compliance with all federal and local agencies. Applicants should have strong clinical trial experience familiar with oversight of studies, assignment of studies to clinical research personnel, and supervision of research staff.

Qualifications:
• This is a hybrid position and applicants must be able to commute to our Los Angeles work location a few times per week. Applicants must reside in the commutable area.
• High School Diploma/GED required.
• Bachelor’s Degree in Science, Sociology, or a related field preferred.
• 4+ years of clinical research–related experience.

Follow the application link if you’re ready to be a part of Cedars-Sinai Cancer’s impactful clinical research.

Apply here:
https://careers.cshs.org/job/beverly-hills/clinical-research-coordinator-iii-hybrid/252/94065243472

09/17/2026

09/17/2026

"Remarkable milestones achieved this year alone demonstrate what is possible through sustained federal investment in cancer research," writes NCI Director Dr. Anthony Letai in NCI's FY28 Professional Judgment Budget Proposal.

"Recent results showing that the drug daraxonrasib extends survival for people with pancreatic cancer have demonstrated that the once 'undruggable' RAS family of genes can, in fact, be targeted—bringing new hope against one of the most deadly cancers."

Learn more about how sustained investment in government-supported science saves lives: https://go.nih.gov/Bi5653J

09/17/2026

09/17/2026

09/15/2026

Dr. Robert Figlin was interviewed on the Becker’s Oncology Leadership Podcast. The podcast covers the pressures facing cancer centers and Cedars-Sinai Cancer’s priority of improving patient access to specialized cancer care while expanding opportunities for clinical trial enrollment. Dr. Figlin offered his views of using AI to holistically streamline care delivery, patient education, and our cancer center’s workforce. He also discussed the challenges facing future cancer center leadership and expressed his optimism about the promising advances he has witnessed in patient treatments.
Becker's Hospital Review

Click to see the podcast: https://podcasts.apple.com/us/podcast/expanding-cancer-care-access-ai-and-the-future/id6789302288?i=1000776247305

09/15/2026

Cedars-Sinai is seeking qualified applicants for the inaugural Director of the new Cayton BRCA Center. The Center will be the first of its kind in Southern California, treating women and men with BRCA genetic mutations and providing coordinated screening, genetic counseling, fertility planning, treatment, and preventive care in one location.

The Director of the Cayton BRCA Center will provide overall executive direction and strategic leadership for all clinical, operational, academic, fundraising, and business development activities involving the Center while being consistent with the highest goals and aspirations of Cedars-Sinai. This is an exceptional opportunity to lead the development of a center dedicated to advancing comprehensive care, research, and innovation in the treatment of individuals with hereditary cancer risk.

Qualifications:
• MD, MD/PhD, or equivalent
• Board Certification in area of expertise
• Ability to obtain and maintain Cedars-Sinai Medical Center Medical Staff Membership
• Ability to obtain and maintain an unrestricted California medical license
• Eligible for recommendation to an Associate Professor or Professor rank in the Medical Center’s professoriate series
• Demonstrated national scientific leadership in BRCA or other hereditary cancers

The successful candidate will join Cedars-Sinai at a pivotal moment, shaping the vision and growth of the Cayton BRCA Center while working alongside nationally recognized clinicians, scientists, and leaders committed to transforming patient care. We welcome all qualified candidates who are passionate about multidisciplinary collaboration, academic excellence, and improving outcomes for patients and families affected by BRCA mutations and other hereditary cancer syndromes.

Follow the link to apply:
https://careers.cshs.org/job/los-angeles/brca-center-director/252/94786561440